ANI Pharmaceuticals Inc

NASDAQ:ANIP   3:59:51 PM EDT
32.08
+0.28 (+0.88%)
Products

Ani Pharmaceuticals Announces FDA Acceptance Of Purified Cortrophin® Gel Supplemental New Drug Application For Multiple Indications

Published: 08/31/2021 11:32 GMT
ANI Pharmaceuticals Inc (ANIP) - Ani Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, and Nephrotic Syndrome.
Ani Pharmaceuticals Inc - Prescription Drug User Fee Act Target Action Date is October 29, 2021.